Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 52.34% is 392% above its 5-year average of 10.65%, near the high end of its 5-year range (4.74%–52.34%).
As of the fiscal period ended Tuesday, June 30, 2026. 167.71% above its 12-month average of 19.55%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 52.34%.
DEBT TO ASSETS RATIO
52.34%
DEBT TO ASSETS RATIO AVG TTM
19.55%
DEBT TO ASSETS RATIO AVG 3Y
10.39%
DEBT TO ASSETS RATIO AVG 5Y
10.65%
DEBT TO ASSETS RATIO AVG 10Y
12.78%
DEBT TO ASSETS RATIO AVG 15Y
11.58%
DEBT TO ASSETS RATIO AVG 20Y
10.07%
CURRENT VS TTM AVG
+167.71%
CURRENT VS 3Y AVG
+403.71%
CURRENT VS 5Y AVG
+391.51%
CURRENT VS 10Y AVG
+309.52%
CURRENT VS 15Y AVG
+352.03%
CURRENT VS 20Y AVG
+419.87%
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 592 covered companies
CURRENT VS SECTOR MEDIAN
+52239.93%
vs the sector median at left
Imunon, Inc.
Market Cap
$5.21M
Debt to Assets Ratio
52.34%
TTM Avg
19.55%
3Y Avg
10.39%
5Y Avg
10.65%
Market Cap
$5.20M
Debt to Assets Ratio
0.42%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.27M
Debt to Assets Ratio
0.15%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.31M
Debt to Assets Ratio
0.49%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.55M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.87M
Debt to Assets Ratio
0.25%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.79M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Imunon, Inc. (IMNN) | $5.21M | 52.34% | 19.55% | 10.39% | 10.65% |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.20M | 0.42% | N/A | N/A | N/A |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.27M | 0.15% | N/A | N/A | N/A |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.31M | 0.49% | N/A | N/A | N/A |
| Alzamend Neuro Inc (ALZN)vs › | $5.34M | 0.00% | N/A | N/A | N/A |
| Lunai Bioworks Inc. (LNAI)vs › | $5.37M | 0.14% | N/A | N/A | N/A |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.55M | 0.00% | N/A | N/A | N/A |
| Gelteq Limited Ordinary Shares (GELS)vs › | $4.87M | 0.25% | N/A | N/A | N/A |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.79M | 0.02% | N/A | N/A | N/A |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.75M | 0.00% | N/A | N/A | N/A |
Debt/Assets
52.3%
Debt/Equity
1.87
Current Ratio
1.82
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 52.34% |
| 2026-03-31 | 11.37% |
| 2025-12-31 | 8.20% |
| 2025-09-30 | 12.26% |
| 2025-06-30 | 13.58% |
| 2025-03-31 | 14.69% |
| 2024-12-31 | 11.72% |
| 2024-09-30 | 8.80% |
| 2024-06-30 | 14.33% |
| 2024-03-31 | 10.53% |
| 2023-12-31 | 7.41% |
| 2023-09-30 | 7.04% |
| 2023-06-30 | 4.74% |
| 2023-03-31 | 17.98% |
| 2022-12-31 | 14.25% |
| 2022-09-30 | 10.51% |
| 2022-06-30 | 9.89% |
| 2022-03-31 | 10.18% |
| 2021-12-31 | 8.96% |
| 2021-09-30 | 8.45% |
| 2021-06-30 | 8.07% |
| 2021-03-31 | 8.39% |
| 2020-12-31 | 16.51% |
| 2020-09-30 | 16.87% |
| 2020-06-30 | 24.27% |
| 2020-03-31 | 29.12% |
| 2019-12-31 | 29.61% |
| 2019-09-30 | 27.93% |
| 2019-06-30 | 25.97% |
| 2019-03-31 | 24.89% |
| 2018-12-31 | 20.10% |
| 2018-09-30 | 22.78% |
| 2018-06-30 | 18.63% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 4.78% |
| 2016-12-31 | 8.30% |
| 2016-09-30 | 9.59% |
| 2016-06-30 | 10.52% |
| 2016-03-31 | 12.74% |
| 2015-12-31 | 13.10% |
| 2015-09-30 | 13.64% |
| 2015-06-30 | 13.49% |
| 2015-03-31 | 14.96% |
| 2014-12-31 | 14.55% |
| 2014-09-30 | 13.03% |
| 2014-06-30 | 12.12% |
| 2014-03-31 | 9.14% |
| 2013-12-31 | 10.97% |
| 2013-09-30 | 9.05% |
| 2013-06-30 | 9.32% |
| 2013-03-31 | 10.54% |
| 2012-12-31 | 20.00% |
| 2012-09-30 | 20.01% |
| 2012-06-30 | 19.22% |
| 2012-03-31 | 0.50% |
| 2011-12-31 | 0.56% |
| 2011-09-30 | 0.38% |
| 2011-06-30 | 1.74% |
| 2011-03-31 | 3.13% |
| 2010-12-31 | 7.12% |
| 2010-09-30 | 4.96% |
| 2010-06-30 | 3.59% |
| 2010-03-31 | 2.37% |
| 2009-12-31 | 1.95% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.29% |
| 2008-12-31 | 0.99% |
| 2008-09-30 | 1.57% |
| 2008-06-30 | 1.93% |
| 2008-03-31 | 2.20% |
| 2007-12-31 | 2.34% |
| 2007-09-30 | 2.40% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 99.86% |
| 2006-12-31 | 85.99% |
| 2006-09-30 | 77.65% |
| 2006-06-30 | 69.81% |
| 2006-03-31 | 57.35% |
| 2005-12-31 | 38.83% |
| 2005-09-30 | 34.84% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 2.35% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 0.00% |
| 2002-12-31 | 18.94% |
| 2002-09-30 | 0.00% |
